nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—PLA2G4A—Epirubicin—uterine cancer	0.215	0.449	CbGbCtD
Fluocinolone Acetonide—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.158	0.332	CbGbCtD
Fluocinolone Acetonide—NR3C1—Progesterone—uterine cancer	0.105	0.22	CbGbCtD
Fluocinolone Acetonide—Flurandrenolide—Medroxyprogesterone Acetate—uterine cancer	0.0967	0.224	CrCrCtD
Fluocinolone Acetonide—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0762	0.176	CrCrCtD
Fluocinolone Acetonide—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.0707	0.164	CrCrCtD
Fluocinolone Acetonide—Fludrocortisone—Progesterone—uterine cancer	0.0664	0.154	CrCrCtD
Fluocinolone Acetonide—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.0661	0.153	CrCrCtD
Fluocinolone Acetonide—Prednisolone—Progesterone—uterine cancer	0.0564	0.13	CrCrCtD
Fluocinolone Acetonide—SERPINA6—oviduct—uterine cancer	0.00669	0.199	CbGeAlD
Fluocinolone Acetonide—Macular oedema—Medroxyprogesterone Acetate—uterine cancer	0.00264	0.0509	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—myometrium—uterine cancer	0.00215	0.064	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—uterine cervix—uterine cancer	0.00167	0.0498	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—smooth muscle tissue—uterine cancer	0.00163	0.0484	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—decidua—uterine cancer	0.00159	0.0474	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—renal system—uterine cancer	0.00156	0.0466	CbGeAlD
Fluocinolone Acetonide—SERPINA6—renal system—uterine cancer	0.00156	0.0464	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—endometrium—uterine cancer	0.00151	0.045	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—mammalian vulva—uterine cancer	0.00146	0.0436	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—female reproductive system—uterine cancer	0.00125	0.0373	CbGeAlD
Fluocinolone Acetonide—SERPINA6—female reproductive system—uterine cancer	0.00125	0.0372	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—female gonad—uterine cancer	0.00114	0.0339	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—vagina—uterine cancer	0.00113	0.0337	CbGeAlD
Fluocinolone Acetonide—NR3C1—myometrium—uterine cancer	0.000937	0.0279	CbGeAlD
Fluocinolone Acetonide—Abscess—Progesterone—uterine cancer	0.0009	0.0173	CcSEcCtD
Fluocinolone Acetonide—Abscess—Medroxyprogesterone Acetate—uterine cancer	0.000816	0.0157	CcSEcCtD
Fluocinolone Acetonide—Folliculitis—Dactinomycin—uterine cancer	0.000801	0.0154	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Progesterone—uterine cancer	0.000788	0.0152	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Progesterone—uterine cancer	0.000773	0.0149	CcSEcCtD
Fluocinolone Acetonide—NR3C1—epithelium—uterine cancer	0.000736	0.0219	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—lymph node—uterine cancer	0.000733	0.0218	CbGeAlD
Fluocinolone Acetonide—NR3C1—uterine cervix—uterine cancer	0.000729	0.0217	CbGeAlD
Fluocinolone Acetonide—NR3C1—smooth muscle tissue—uterine cancer	0.000709	0.0211	CbGeAlD
Fluocinolone Acetonide—NR3C1—decidua—uterine cancer	0.000695	0.0207	CbGeAlD
Fluocinolone Acetonide—Secondary infection—Epirubicin—uterine cancer	0.000695	0.0134	CcSEcCtD
Fluocinolone Acetonide—NR3C1—renal system—uterine cancer	0.000682	0.0203	CbGeAlD
Fluocinolone Acetonide—NR3C1—endometrium—uterine cancer	0.00066	0.0196	CbGeAlD
Fluocinolone Acetonide—Secondary infection—Doxorubicin—uterine cancer	0.000643	0.0124	CcSEcCtD
Fluocinolone Acetonide—NR3C1—mammalian vulva—uterine cancer	0.000638	0.019	CbGeAlD
Fluocinolone Acetonide—NR3C1—uterus—uterine cancer	0.000608	0.0181	CbGeAlD
Fluocinolone Acetonide—Ear pain—Progesterone—uterine cancer	0.000606	0.0117	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Progesterone—uterine cancer	0.000583	0.0112	CcSEcCtD
Fluocinolone Acetonide—Rash papular—Epirubicin—uterine cancer	0.000548	0.0106	CcSEcCtD
Fluocinolone Acetonide—NR3C1—female reproductive system—uterine cancer	0.000547	0.0163	CbGeAlD
Fluocinolone Acetonide—Visual disturbance—Progesterone—uterine cancer	0.000545	0.0105	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Progesterone—uterine cancer	0.000517	0.00995	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Progesterone—uterine cancer	0.000517	0.00995	CcSEcCtD
Fluocinolone Acetonide—Rash papular—Doxorubicin—uterine cancer	0.000507	0.00976	CcSEcCtD
Fluocinolone Acetonide—NR3C1—female gonad—uterine cancer	0.000497	0.0148	CbGeAlD
Fluocinolone Acetonide—Visual disturbance—Medroxyprogesterone Acetate—uterine cancer	0.000494	0.00951	CcSEcCtD
Fluocinolone Acetonide—NR3C1—vagina—uterine cancer	0.000494	0.0147	CbGeAlD
Fluocinolone Acetonide—Fungal skin infection—Epirubicin—uterine cancer	0.000489	0.00941	CcSEcCtD
Fluocinolone Acetonide—Infection—Carboplatin—uterine cancer	0.00048	0.00925	CcSEcCtD
Fluocinolone Acetonide—Leukoderma—Epirubicin—uterine cancer	0.00048	0.00925	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00048	0.00924	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Medroxyprogesterone Acetate—uterine cancer	0.000468	0.00902	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Progesterone—uterine cancer	0.000462	0.0089	CcSEcCtD
Fluocinolone Acetonide—Fungal skin infection—Doxorubicin—uterine cancer	0.000452	0.00871	CcSEcCtD
Fluocinolone Acetonide—Leukoderma—Doxorubicin—uterine cancer	0.000444	0.00856	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.000419	0.00806	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Progesterone—uterine cancer	0.000415	0.00799	CcSEcCtD
Fluocinolone Acetonide—Pain—Carboplatin—uterine cancer	0.000414	0.00796	CcSEcCtD
Fluocinolone Acetonide—Influenza—Medroxyprogesterone Acetate—uterine cancer	0.000405	0.00779	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Progesterone—uterine cancer	0.000398	0.00767	CcSEcCtD
Fluocinolone Acetonide—Infestation—Progesterone—uterine cancer	0.000398	0.00767	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Carboplatin—uterine cancer	0.000382	0.00736	CcSEcCtD
Fluocinolone Acetonide—Fluticasone Propionate—PGR—uterine cancer	0.000381	0.241	CrCbGaD
Fluocinolone Acetonide—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.000376	0.00724	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Progesterone—uterine cancer	0.000374	0.00719	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Medroxyprogesterone Acetate—uterine cancer	0.000361	0.00695	CcSEcCtD
Fluocinolone Acetonide—Infestation—Medroxyprogesterone Acetate—uterine cancer	0.000361	0.00695	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Progesterone—uterine cancer	0.000359	0.0069	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Progesterone—uterine cancer	0.000351	0.00676	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—PGR—uterine cancer	0.00035	0.221	CrCbGaD
Fluocinolone Acetonide—Lacrimation—Epirubicin—uterine cancer	0.000347	0.00668	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Progesterone—uterine cancer	0.000345	0.00663	CcSEcCtD
Fluocinolone Acetonide—Skin hyperpigmentation—Epirubicin—uterine cancer	0.000343	0.00661	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.000339	0.00652	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Progesterone—uterine cancer	0.000334	0.00643	CcSEcCtD
Fluocinolone Acetonide—Folliculitis—Epirubicin—uterine cancer	0.000325	0.00625	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Progesterone—uterine cancer	0.000322	0.0062	CcSEcCtD
Fluocinolone Acetonide—Lacrimation—Doxorubicin—uterine cancer	0.000321	0.00619	CcSEcCtD
Fluocinolone Acetonide—NR3C1—lymph node—uterine cancer	0.00032	0.00952	CbGeAlD
Fluocinolone Acetonide—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.000318	0.00613	CcSEcCtD
Fluocinolone Acetonide—Skin hyperpigmentation—Doxorubicin—uterine cancer	0.000318	0.00611	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Progesterone—uterine cancer	0.000316	0.00608	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Progesterone—uterine cancer	0.000313	0.00603	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.000312	0.00601	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Progesterone—uterine cancer	0.000311	0.00599	CcSEcCtD
Fluocinolone Acetonide—Erythema—Progesterone—uterine cancer	0.000311	0.00599	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.000303	0.00583	CcSEcCtD
Fluocinolone Acetonide—Back pain—Progesterone—uterine cancer	0.000301	0.0058	CcSEcCtD
Fluocinolone Acetonide—Folliculitis—Doxorubicin—uterine cancer	0.000301	0.00579	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Progesterone—uterine cancer	0.000293	0.00565	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000292	0.00562	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000286	0.00551	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.000284	0.00546	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.000282	0.00543	CcSEcCtD
Fluocinolone Acetonide—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.000282	0.00543	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Progesterone—uterine cancer	0.00028	0.00538	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.000276	0.00532	CcSEcCtD
Fluocinolone Acetonide—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.000273	0.00525	CcSEcCtD
Fluocinolone Acetonide—Cough—Progesterone—uterine cancer	0.000272	0.00523	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP11A1—uterine cancer	0.00027	0.17	CrCbGaD
Fluocinolone Acetonide—Arthralgia—Progesterone—uterine cancer	0.000265	0.0051	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Epirubicin—uterine cancer	0.000262	0.00505	CcSEcCtD
Fluocinolone Acetonide—Abscess—Epirubicin—uterine cancer	0.000258	0.00497	CcSEcCtD
Fluocinolone Acetonide—Rash pustular—Epirubicin—uterine cancer	0.000256	0.00493	CcSEcCtD
Fluocinolone Acetonide—Oedema—Progesterone—uterine cancer	0.000254	0.00489	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.000253	0.00488	CcSEcCtD
Fluocinolone Acetonide—Infection—Progesterone—uterine cancer	0.000252	0.00486	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Progesterone—uterine cancer	0.000249	0.0048	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Doxorubicin—uterine cancer	0.000243	0.00467	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00024	0.00462	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—CYP19A1—uterine cancer	0.00024	0.151	CrCbGaD
Fluocinolone Acetonide—Abscess—Doxorubicin—uterine cancer	0.000239	0.0046	CcSEcCtD
Fluocinolone Acetonide—Rash pustular—Doxorubicin—uterine cancer	0.000237	0.00456	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000231	0.00446	CcSEcCtD
Fluocinolone Acetonide—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00023	0.00443	CcSEcCtD
Fluocinolone Acetonide—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000229	0.0044	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Epirubicin—uterine cancer	0.000226	0.00435	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000226	0.00435	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Dactinomycin—uterine cancer	0.000223	0.0043	CcSEcCtD
Fluocinolone Acetonide—Lacrimation increased—Epirubicin—uterine cancer	0.000222	0.00427	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Epirubicin—uterine cancer	0.000222	0.00427	CcSEcCtD
Fluocinolone Acetonide—Erythema—Dactinomycin—uterine cancer	0.00022	0.00424	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Progesterone—uterine cancer	0.000219	0.00422	CcSEcCtD
Fluocinolone Acetonide—Pain—Progesterone—uterine cancer	0.000217	0.00418	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00021	0.00404	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Doxorubicin—uterine cancer	0.000209	0.00403	CcSEcCtD
Fluocinolone Acetonide—Neck pain—Epirubicin—uterine cancer	0.000207	0.00398	CcSEcCtD
Fluocinolone Acetonide—Lacrimation increased—Doxorubicin—uterine cancer	0.000205	0.00395	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Doxorubicin—uterine cancer	0.000205	0.00395	CcSEcCtD
Fluocinolone Acetonide—Infestation—Etoposide—uterine cancer	0.000204	0.00392	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Etoposide—uterine cancer	0.000204	0.00392	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—PGR—uterine cancer	0.000203	0.128	CrCbGaD
Fluocinolone Acetonide—Dermatitis contact—Epirubicin—uterine cancer	0.000202	0.00388	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Progesterone—uterine cancer	0.000201	0.00387	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000199	0.00383	CcSEcCtD
Fluocinolone Acetonide—Neck pain—Doxorubicin—uterine cancer	0.000191	0.00368	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Epirubicin—uterine cancer	0.000189	0.00363	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Progesterone—uterine cancer	0.000187	0.0036	CcSEcCtD
Fluocinolone Acetonide—Dermatitis contact—Doxorubicin—uterine cancer	0.000187	0.00359	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000182	0.0035	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Progesterone—uterine cancer	0.00018	0.00346	CcSEcCtD
Fluocinolone Acetonide—Oedema—Dactinomycin—uterine cancer	0.00018	0.00346	CcSEcCtD
Fluocinolone Acetonide—Infection—Dactinomycin—uterine cancer	0.000178	0.00343	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Doxorubicin—uterine cancer	0.000175	0.00336	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Progesterone—uterine cancer	0.000174	0.00335	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Etoposide—uterine cancer	0.000171	0.00329	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00017	0.00326	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Progesterone—uterine cancer	0.000168	0.00323	CcSEcCtD
Fluocinolone Acetonide—Eczema—Epirubicin—uterine cancer	0.000165	0.00317	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Etoposide—uterine cancer	0.000165	0.00317	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Epirubicin—uterine cancer	0.000164	0.00316	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000164	0.00315	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000163	0.00314	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Etoposide—uterine cancer	0.000162	0.00311	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Progesterone—uterine cancer	0.000162	0.00311	CcSEcCtD
Fluocinolone Acetonide—Rash—Progesterone—uterine cancer	0.00016	0.00308	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Progesterone—uterine cancer	0.00016	0.00308	CcSEcCtD
Fluocinolone Acetonide—Headache—Progesterone—uterine cancer	0.000159	0.00306	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000158	0.00303	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Etoposide—uterine cancer	0.000156	0.003	CcSEcCtD
Fluocinolone Acetonide—Back pain—Etoposide—uterine cancer	0.000154	0.00297	CcSEcCtD
Fluocinolone Acetonide—Pain—Dactinomycin—uterine cancer	0.000154	0.00296	CcSEcCtD
Fluocinolone Acetonide—Eczema—Doxorubicin—uterine cancer	0.000153	0.00294	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000152	0.00293	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Doxorubicin—uterine cancer	0.000152	0.00292	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Epirubicin—uterine cancer	0.000152	0.00292	CcSEcCtD
Fluocinolone Acetonide—Nausea—Progesterone—uterine cancer	0.000151	0.0029	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Epirubicin—uterine cancer	0.000148	0.00285	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Epirubicin—uterine cancer	0.000148	0.00285	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000146	0.00282	CcSEcCtD
Fluocinolone Acetonide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000145	0.00279	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000145	0.00279	CcSEcCtD
Fluocinolone Acetonide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000144	0.00278	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Prostaglandin Synthesis and Regulation—CYP11A1—uterine cancer	0.000144	0.0536	CbGpPWpGaD
Fluocinolone Acetonide—Vertigo—Etoposide—uterine cancer	0.000143	0.00275	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Dactinomycin—uterine cancer	0.000142	0.00273	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Doxorubicin—uterine cancer	0.000141	0.00271	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP19A1—uterine cancer	0.000139	0.0881	CrCbGaD
Fluocinolone Acetonide—Cough—Etoposide—uterine cancer	0.000139	0.00267	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Doxorubicin—uterine cancer	0.000137	0.00264	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Doxorubicin—uterine cancer	0.000137	0.00264	CcSEcCtD
Fluocinolone Acetonide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000137	0.00263	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Epirubicin—uterine cancer	0.000133	0.00255	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Dactinomycin—uterine cancer	0.000132	0.00255	CcSEcCtD
Fluocinolone Acetonide—Infection—Etoposide—uterine cancer	0.000129	0.00249	CcSEcCtD
Fluocinolone Acetonide—Influenza—Epirubicin—uterine cancer	0.000128	0.00247	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Dactinomycin—uterine cancer	0.000123	0.00237	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Doxorubicin—uterine cancer	0.000123	0.00236	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000119	0.00229	CcSEcCtD
Fluocinolone Acetonide—Influenza—Doxorubicin—uterine cancer	0.000119	0.00228	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Epirubicin—uterine cancer	0.000114	0.0022	CcSEcCtD
Fluocinolone Acetonide—Infestation—Epirubicin—uterine cancer	0.000114	0.0022	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Dactinomycin—uterine cancer	0.000114	0.0022	CcSEcCtD
Fluocinolone Acetonide—Rash—Dactinomycin—uterine cancer	0.000113	0.00218	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Etoposide—uterine cancer	0.000112	0.00216	CcSEcCtD
Fluocinolone Acetonide—Pain—Etoposide—uterine cancer	0.000111	0.00214	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00011	0.00212	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Epirubicin—uterine cancer	0.000107	0.00206	CcSEcCtD
Fluocinolone Acetonide—Nausea—Dactinomycin—uterine cancer	0.000107	0.00205	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Doxorubicin—uterine cancer	0.000106	0.00203	CcSEcCtD
Fluocinolone Acetonide—Infestation—Doxorubicin—uterine cancer	0.000106	0.00203	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Epirubicin—uterine cancer	0.000103	0.00198	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Etoposide—uterine cancer	0.000103	0.00198	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Epirubicin—uterine cancer	0.000101	0.00194	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Doxorubicin—uterine cancer	9.92e-05	0.00191	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Epirubicin—uterine cancer	9.88e-05	0.0019	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Epirubicin—uterine cancer	9.58e-05	0.00184	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Etoposide—uterine cancer	9.58e-05	0.00184	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Doxorubicin—uterine cancer	9.51e-05	0.00183	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Doxorubicin—uterine cancer	9.32e-05	0.00179	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Epirubicin—uterine cancer	9.24e-05	0.00178	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Etoposide—uterine cancer	9.19e-05	0.00177	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Doxorubicin—uterine cancer	9.14e-05	0.00176	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Epirubicin—uterine cancer	9.06e-05	0.00174	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—AKR1C3—uterine cancer	9.03e-05	0.0336	CbGpPWpGaD
Fluocinolone Acetonide—Mental disorder—Epirubicin—uterine cancer	8.98e-05	0.00173	CcSEcCtD
Fluocinolone Acetonide—Erythema—Epirubicin—uterine cancer	8.93e-05	0.00172	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Epirubicin—uterine cancer	8.93e-05	0.00172	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Etoposide—uterine cancer	8.89e-05	0.00171	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Doxorubicin—uterine cancer	8.87e-05	0.00171	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Epirubicin—uterine cancer	8.74e-05	0.00168	CcSEcCtD
Fluocinolone Acetonide—Back pain—Epirubicin—uterine cancer	8.63e-05	0.00166	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Etoposide—uterine cancer	8.59e-05	0.00165	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Doxorubicin—uterine cancer	8.55e-05	0.00165	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Epirubicin—uterine cancer	8.41e-05	0.00162	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Doxorubicin—uterine cancer	8.38e-05	0.00161	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Doxorubicin—uterine cancer	8.31e-05	0.0016	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Etoposide—uterine cancer	8.26e-05	0.00159	CcSEcCtD
Fluocinolone Acetonide—Erythema—Doxorubicin—uterine cancer	8.26e-05	0.00159	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Doxorubicin—uterine cancer	8.26e-05	0.00159	CcSEcCtD
Fluocinolone Acetonide—Rash—Etoposide—uterine cancer	8.19e-05	0.00158	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Etoposide—uterine cancer	8.19e-05	0.00158	CcSEcCtD
Fluocinolone Acetonide—Headache—Etoposide—uterine cancer	8.14e-05	0.00157	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Doxorubicin—uterine cancer	8.09e-05	0.00156	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Epirubicin—uterine cancer	8.02e-05	0.00154	CcSEcCtD
Fluocinolone Acetonide—Back pain—Doxorubicin—uterine cancer	7.99e-05	0.00154	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	7.98e-05	0.0297	CbGpPWpGaD
Fluocinolone Acetonide—Cough—Epirubicin—uterine cancer	7.79e-05	0.0015	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Doxorubicin—uterine cancer	7.78e-05	0.0015	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptors—PGR—uterine cancer	7.75e-05	0.0289	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Etoposide—uterine cancer	7.72e-05	0.00149	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Epirubicin—uterine cancer	7.6e-05	0.00146	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Doxorubicin—uterine cancer	7.42e-05	0.00143	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Signaling events mediated by HDAC Class II—YWHAE—uterine cancer	7.4e-05	0.0275	CbGpPWpGaD
Fluocinolone Acetonide—Oedema—Epirubicin—uterine cancer	7.29e-05	0.0014	CcSEcCtD
Fluocinolone Acetonide—Infection—Epirubicin—uterine cancer	7.24e-05	0.00139	CcSEcCtD
Fluocinolone Acetonide—Cough—Doxorubicin—uterine cancer	7.21e-05	0.00139	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—HNF1B—uterine cancer	7.21e-05	0.0268	CbGpPWpGaD
Fluocinolone Acetonide—Nervous system disorder—Epirubicin—uterine cancer	7.14e-05	0.00138	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Doxorubicin—uterine cancer	7.03e-05	0.00135	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptors—ESR2—uterine cancer	6.83e-05	0.0254	CbGpPWpGaD
Fluocinolone Acetonide—Oedema—Doxorubicin—uterine cancer	6.74e-05	0.0013	CcSEcCtD
Fluocinolone Acetonide—Infection—Doxorubicin—uterine cancer	6.7e-05	0.00129	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.64e-05	0.00128	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Doxorubicin—uterine cancer	6.61e-05	0.00127	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Epirubicin—uterine cancer	6.29e-05	0.00121	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—ESR1—uterine cancer	6.25e-05	0.0233	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Epirubicin—uterine cancer	6.23e-05	0.0012	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	6.14e-05	0.00118	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—PGR—uterine cancer	6.13e-05	0.0228	CbGpPWpGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.82e-05	0.00112	CcSEcCtD
Fluocinolone Acetonide—Pain—Doxorubicin—uterine cancer	5.76e-05	0.00111	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Epirubicin—uterine cancer	5.76e-05	0.00111	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—ESR2—uterine cancer	5.4e-05	0.0201	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Epirubicin—uterine cancer	5.37e-05	0.00103	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Doxorubicin—uterine cancer	5.33e-05	0.00103	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Epirubicin—uterine cancer	5.15e-05	0.000992	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Epirubicin—uterine cancer	4.98e-05	0.000959	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Doxorubicin—uterine cancer	4.97e-05	0.000956	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Epirubicin—uterine cancer	4.82e-05	0.000927	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Doxorubicin—uterine cancer	4.77e-05	0.000918	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Epirubicin—uterine cancer	4.63e-05	0.000892	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—EZH2—uterine cancer	4.62e-05	0.0172	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Doxorubicin—uterine cancer	4.61e-05	0.000888	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—SMAD3—uterine cancer	4.61e-05	0.0172	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Epirubicin—uterine cancer	4.59e-05	0.000884	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Epirubicin—uterine cancer	4.59e-05	0.000883	CcSEcCtD
Fluocinolone Acetonide—Headache—Epirubicin—uterine cancer	4.56e-05	0.000879	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	4.46e-05	0.0166	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Doxorubicin—uterine cancer	4.46e-05	0.000858	CcSEcCtD
Fluocinolone Acetonide—Nausea—Epirubicin—uterine cancer	4.33e-05	0.000833	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Doxorubicin—uterine cancer	4.29e-05	0.000825	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IRF1—uterine cancer	4.28e-05	0.0159	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Doxorubicin—uterine cancer	4.25e-05	0.000818	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Doxorubicin—uterine cancer	4.25e-05	0.000817	CcSEcCtD
Fluocinolone Acetonide—Headache—Doxorubicin—uterine cancer	4.22e-05	0.000813	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptors—ESR1—uterine cancer	4.14e-05	0.0154	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—uterine cancer	4.14e-05	0.0154	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—YWHAE—uterine cancer	4.03e-05	0.015	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Doxorubicin—uterine cancer	4e-05	0.000771	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—uterine cancer	3.27e-05	0.0122	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—SMAD3—uterine cancer	3.19e-05	0.0119	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.16e-05	0.0118	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	3.03e-05	0.0113	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—HMGA1—uterine cancer	2.9e-05	0.0108	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	2.86e-05	0.0107	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	2.77e-05	0.0103	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	2.67e-05	0.00994	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	2.65e-05	0.00987	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—uterine cancer	2.61e-05	0.00973	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—ESR1—uterine cancer	2.54e-05	0.00946	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—uterine cancer	2.52e-05	0.0094	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.41e-05	0.00896	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—YWHAE—uterine cancer	2.39e-05	0.0089	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGF Pathway—HRAS—uterine cancer	2.34e-05	0.00872	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.28e-05	0.0085	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.28e-05	0.0085	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	2.26e-05	0.00841	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CCL2—uterine cancer	2.24e-05	0.00833	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—ESR2—uterine cancer	2.21e-05	0.00821	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—SOCS3—uterine cancer	2.17e-05	0.00808	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.16e-05	0.00804	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CDKN2A—uterine cancer	1.95e-05	0.00726	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—SMAD3—uterine cancer	1.9e-05	0.00706	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of Androgen receptor activity—EP300—uterine cancer	1.89e-05	0.00705	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Circadian Clock—EP300—uterine cancer	1.84e-05	0.00685	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—PIK3CA—uterine cancer	1.77e-05	0.00659	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CXCL8—uterine cancer	1.77e-05	0.00658	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CDKN1B—uterine cancer	1.73e-05	0.00643	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.68e-05	0.00624	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—CTNNB1—uterine cancer	1.67e-05	0.00622	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—uterine cancer	1.64e-05	0.0061	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CTNNB1—uterine cancer	1.63e-05	0.00607	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.61e-05	0.00599	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—HRAS—uterine cancer	1.6e-05	0.00594	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—PTEN—uterine cancer	1.59e-05	0.00592	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—uterine cancer	1.56e-05	0.0058	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—EP300—uterine cancer	1.52e-05	0.00564	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—uterine cancer	1.45e-05	0.00538	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PHF1—uterine cancer	1.44e-05	0.00535	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—PTEN—uterine cancer	1.41e-05	0.00526	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IRF1—uterine cancer	1.41e-05	0.00525	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—AKT1—uterine cancer	1.41e-05	0.00525	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SRD5A2—uterine cancer	1.41e-05	0.00524	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NDUFB11—uterine cancer	1.41e-05	0.00524	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.37e-05	0.00509	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—AKT1—uterine cancer	1.36e-05	0.00505	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	1.35e-05	0.00502	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—uterine cancer	1.34e-05	0.00497	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	1.33e-05	0.00495	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PTEN—uterine cancer	1.31e-05	0.00486	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.29e-05	0.0048	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—NRAS—uterine cancer	1.26e-05	0.00469	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CHD4—uterine cancer	1.22e-05	0.00455	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.18e-05	0.00439	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.09e-05	0.00407	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TP53—uterine cancer	1.08e-05	0.00404	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—KRAS—uterine cancer	1.08e-05	0.00404	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PGR—uterine cancer	1.06e-05	0.00394	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.03e-05	0.00384	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SUZ12—uterine cancer	1.02e-05	0.00381	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKR1B1—uterine cancer	1.02e-05	0.00379	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—STAR—uterine cancer	1.02e-05	0.00379	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.01e-05	0.00375	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.01e-05	0.00374	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—uterine cancer	9.97e-06	0.00371	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—CTNNB1—uterine cancer	9.94e-06	0.0037	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	9.6e-06	0.00357	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—uterine cancer	9.56e-06	0.00356	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—ESR2—uterine cancer	9.32e-06	0.00347	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	9.31e-06	0.00347	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—HRAS—uterine cancer	9.22e-06	0.00343	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PIK3CA—uterine cancer	9.21e-06	0.00343	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKR1B10—uterine cancer	9.15e-06	0.00341	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	9.09e-06	0.00338	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	8.59e-06	0.0032	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	8.15e-06	0.00304	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	8.09e-06	0.00301	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	8.07e-06	0.00301	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—EP300—uterine cancer	7.99e-06	0.00297	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—POLD1—uterine cancer	7.98e-06	0.00297	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	7.73e-06	0.00288	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—CDKN2B—uterine cancer	7.59e-06	0.00282	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RNF43—uterine cancer	7.58e-06	0.00282	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	7.56e-06	0.00282	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKR1C1—uterine cancer	7.47e-06	0.00278	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	7.1e-06	0.00264	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—INHBA—uterine cancer	6.93e-06	0.00258	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—SMAD3—uterine cancer	6.93e-06	0.00258	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	6.87e-06	0.00256	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—RRM2—uterine cancer	6.65e-06	0.00248	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—DCN—uterine cancer	6.46e-06	0.00241	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	6.32e-06	0.00235	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKR1C1—uterine cancer	6.24e-06	0.00232	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP11A1—uterine cancer	6.09e-06	0.00227	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.8e-06	0.00216	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKR1C3—uterine cancer	5.75e-06	0.00214	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—ESR1—uterine cancer	5.65e-06	0.0021	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—uterine cancer	5.16e-06	0.00192	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PGR—uterine cancer	5.1e-06	0.0019	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—EZH2—uterine cancer	4.84e-06	0.0018	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKR1C3—uterine cancer	4.81e-06	0.00179	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PGR—uterine cancer	4.68e-06	0.00174	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ESR2—uterine cancer	4.49e-06	0.00167	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—STK11—uterine cancer	4.48e-06	0.00167	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP19A1—uterine cancer	4.48e-06	0.00167	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—YWHAE—uterine cancer	4.47e-06	0.00166	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—EP300—uterine cancer	4.4e-06	0.00164	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FBXW7—uterine cancer	4.28e-06	0.00159	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.2e-06	0.00156	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—uterine cancer	4.17e-06	0.00155	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NRAS—uterine cancer	4.12e-06	0.00153	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.01e-06	0.00149	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STK11—uterine cancer	3.74e-06	0.00139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL2—uterine cancer	3.73e-06	0.00139	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CDKN2B—uterine cancer	3.65e-06	0.00136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—KRAS—uterine cancer	3.54e-06	0.00132	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SOCS3—uterine cancer	3.51e-06	0.00131	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTHFR—uterine cancer	3.36e-06	0.00125	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN2B—uterine cancer	3.36e-06	0.00125	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SMAD3—uterine cancer	3.33e-06	0.00124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1R—uterine cancer	3.26e-06	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CA—uterine cancer	3.26e-06	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—uterine cancer	3.15e-06	0.00117	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SMAD3—uterine cancer	3.06e-06	0.00114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—HRAS—uterine cancer	3.01e-06	0.00112	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.96e-06	0.0011	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL8—uterine cancer	2.95e-06	0.0011	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGFR2—uterine cancer	2.92e-06	0.00109	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ESR1—uterine cancer	2.72e-06	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—uterine cancer	2.66e-06	0.000991	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ESR1—uterine cancer	2.5e-06	0.000931	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—NRAS—uterine cancer	2.36e-06	0.00088	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL2—uterine cancer	2.2e-06	0.00082	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—KRAS—uterine cancer	2.03e-06	0.000757	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTEN—uterine cancer	1.87e-06	0.000697	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CA—uterine cancer	1.87e-06	0.000696	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ERBB2—uterine cancer	1.84e-06	0.000683	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—EP300—uterine cancer	1.78e-06	0.000665	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL8—uterine cancer	1.74e-06	0.000648	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HRAS—uterine cancer	1.73e-06	0.000644	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1B—uterine cancer	1.7e-06	0.000633	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CTNNB1—uterine cancer	1.61e-06	0.000598	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTEN—uterine cancer	1.57e-06	0.000583	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—uterine cancer	1.53e-06	0.000569	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EP300—uterine cancer	1.49e-06	0.000556	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—uterine cancer	1.41e-06	0.000526	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NRAS—uterine cancer	1.4e-06	0.00052	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CA—uterine cancer	1.32e-06	0.000492	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KRAS—uterine cancer	1.2e-06	0.000447	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CA—uterine cancer	1.1e-06	0.000411	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—uterine cancer	1.08e-06	0.000402	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—uterine cancer	1.07e-06	0.000398	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HRAS—uterine cancer	1.02e-06	0.00038	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—uterine cancer	9.82e-07	0.000365	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—uterine cancer	9.02e-07	0.000336	CbGpPWpGaD
